WILMINGTON, N.C. — The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. Thermo Fisher Bioanalytical lab The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and […]
Uppsala, Sweden – Navinci today announced the launch of the Naveni® Plex Omni Service, a new offering that provides researchers with advanced access to spatial interactomics through the company’s proprietary multiplex in situ proximity ligation assay (misPLA) technology, run by the experts that developed it. Naveni® Plex Omni allows scientists to map protein function and networks in spatial context, to […]
OKLAHOMA CITY, Okla. — HLA Protein Technologies, Inc. (formerly Pure Protein, LLC) reports that its new manufacturing expansion is positioned to support the Company’s growth. A new product line launch, a strategic investment led by a private investor group; and a corporate rebrand to HLA Protein Technologies, reflects the company’s expanded focus on advanced immunology […]
The Board of Partners of E. Merck KG, Darmstadt, Germany, appointed Kai Beckmann as future Chair of the Executive Board and CEO. Darmstadt, Germany Belén Garijo’s successful tenure to be completed as planned by end of April 2026 Kai Beckmann appointed as Chair of the Executive Board and CEO effective May 1, 2026, ensuring a […]
Introduction Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases. In upstream development, accurate and timely measurement of mAb concentration is essential for clone selection, process optimisation, and early screening workflows. Conventional techniques such as enzyme-linked immunosorbent assays (ELISA) and conventional high-performance liquid chromatography (HPLC) […]
Combination of Revvity’s proprietary Pin-point platform and Profluent’s AI-engineered proteins created to inspire accelerated development of novel gene editing therapies WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) announced a strategic collaboration with Profluent, bringing together a range of its novel AI-engineered enzymes with Revvity’s established Pin-pointTM base editing platform. The result is simplified access for customers to a therapeutically […]
Tempe, AZ — Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system. Building on the award-winning SPR microscopy technology first launched in 2017, the SPRm 220 brings enhanced throughput, improved usability, and unmatched capability in label-free, cell-based kinetic analysis. Designed specifically for the challenges of membrane protein research, […]
Stockholm, Sweden – Atlas Antibodies proudly announces the launch of AtlasPlex, a complete and customizable multiplex immunohistochemistry (mIHC-IF) solution for FFPE and fresh-frozen tissue. “AtlasPlex marks a significant milestone in Atlas Antibodies’ innovation journey with a strong dedication to preserving and advancing the legacy of the Human Protein Atlas. It’s a testament to what focused innovation and […]
Introduction Adeno-associated virus (AAV) vectors have become a cornerstone of gene therapy, valued for their safety, broad targeting capabilities, and adaptability across therapeutic applications. As development advances from research to process refinement, reliable quantification of total AAV capsid concentration is key to maintaining consistency and supporting informed decision-making. Traditional methods such as ELISA can be […]
Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
